Chargement en cours...
Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study
PURPOSE: We determined the feasibility of substituting sitagliptin or mitiglinide for bolus insulin injection therapy in patients with type 2 diabetes. METHODS: 60 patients with type 2 diabetes were enrolled and randomized to switch from mealtime dosing of a rapid-acting insulin analog to either sit...
Enregistré dans:
| Publié dans: | BMJ Open Diabetes Res Care |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4553908/ https://ncbi.nlm.nih.gov/pubmed/26336611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2015-000122 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|